Huadong Medicine Co (SZSE:000963) Net Income (Continuing Operations) : ¥2,947 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Huadong Medicine Co's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was ¥860 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,947 Mil.

Huadong Medicine Co Net Income (Continuing Operations) Historical Data

The historical data trend for Huadong Medicine Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co Net Income (Continuing Operations) Chart

Huadong Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

2,925.40

2,909.72

2,338.63

2,532.63

2,846.40

Huadong Medicine Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															759.93	679.93	753.69	652.85	860.25

Huadong Medicine Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,947 Mil.

Huadong Medicine Co (SZSE:000963) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Huadong Medicine Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Huadong Medicine Co (SZSE:000963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006

Website

http://www.eastchinapharm.com

Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Executives

He Ru Fen	Supervisors
Hu Bao Zhen	Supervisors
Zhou Shun Hua	Executives
Shao Ling Min	Supervisors
Wan Ling Ling	Executives
Fu Hang	Director
Yue Jin	Director
Chen Bo	Secretary Dong
Qin Yun	Supervisors
Li Bang Liang	Directors, executives
Zhou Jin Bao	Directors, executives

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines